The Oncology Nursing Society (ONS) has announced the release of a new clinical decision support tool designed to bring biomarker advancements to the point of care. Curated by nurses, for nurses, ONS’s new database connects clinicians to information about therapeutic options for certain cancers and their associated biomarkers.
The ONS Biomarker Database provides oncology nurses and other providers with:
• Information and recommendations about biomarkers associated with certain cancers
• Details about patient care and treatment options
• Evidence for treatment decisions in certain cancers
• Support for accurate patient education
“The ONS Biomarker Database was created by genomics experts and ONS members and offers 25 disease tables and more than 250 biomarkers with expansion options,” Kathleen Wiley, RN, MSN, AOCNS®, ONS director of oncology nursing practice, said. “Future content will address pancreatic adenocarcinoma, hepatocellular carcinoma, head and neck cancers, gynecologic cancers, hematologic malignancies, and genitourinary cancers.”
The ONS Biomarker Database has an easy-to-use site search and options to filter results based on biomarker, disease type, or targeted therapy. Nurses at any career level may use it for either direct care in specific patients or general self-education about disease-associated biomarkers.
Experts in each cancer type built original content based on the strongest current evidence about that cancer’s associated biomarkers. All of the content also underwent expert peer review for quality, completeness, and accuracy and is regularly reviewed and updated to reflect the latest advancements and evolution of biomarkers in cancer care.